Selexipag in the management of pulmonary arterial hypertension: an update

Selexipag in the management of pulmonary arterial hypertension: an update

J Gerry Coghlan,1 Christina Picken,2 Lucie H Clapp21Department of Cardiology, Royal Free Hospital, London NW3 2QG, UK; 2Institute of Cardiovascular Sciences, University College London, London WC1E 6JF, UKAbstract: Selexipag is a compound that was designed to overcome the issues associated with oral...

Full description

Bibliographic Details
Main Authors: Coghlan JG, Picken C, Clapp LH
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Drug, Healthcare and Patient Safety
Subjects:
Selexipag
pulmonary arterial hypertension
mortality/morbidity
prostanoid
averse events
prognosis
haemodynamic
Online Access:https://www.dovepress.com/selexipag-in-the-management-of-pulmonary-arterial-hypertension-an-upda-peer-reviewed-article-DHPS

Internet

https://www.dovepress.com/selexipag-in-the-management-of-pulmonary-arterial-hypertension-an-upda-peer-reviewed-article-DHPS

Similar Items